Reyes Cabanillas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sandip P. Patel, MD, reviews data from the preliminary results of the EVOKE-02 study investigating sacituzumab govitecan plus pembrolizumab in first-line metastatic non–small cell lung cancer.

United statesCobo dolsSacituzumab govitecanReyes cabanillasSandipp patelMetastatic nonSmall cell lung cancerPreliminary resultsPartnership withWorld conferenceLung cancerNon small cell lung cancerMetastatic non small cell lung cancerMetastatic nsclcEvoke 02Pd l1 inhibitor